News
Biogen adding $2 billion to its RTP manufacturing campus
One of North Carolina’s largest life sciences companies, Biogen Inc. (Nasdaq BIIB), is celebrating its 30th anniversary in the state by announcing that it intends to invest an additional $2 billion at its two existing Research Triangle Park (RTP) campuses.
Biogen has announced plans to invest an additional $2bn in Research Triangle Park (RTP) in the US state of North Carolina.
Biogen will invest an additional $2 billion in its existing manufacturing in North Carolina, the drugmaker said on Monday, as ...
Biogen Inc. is investing $2 billion in its North Carolina RTP site, expanding manufacturing amid tariff talks.
Investment builds on Biogen’s 30-year history of manufacturing in the region, with approximately $10 billion invested to date ...
Since starting operations in North Carolina 30 years ago, Biogen has spent approximately $10 billion to bolster its ...
Biogen will invest an extra $2 billion to expand its RTP facilities, focusing on AI-driven manufacturing and late-stage ...
Lecanemab presentations to include long-term Clarity AD data, real-world treatment insights, and a subcutaneous formulation ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback